BioFluidica, Inc. Sustainability Profile
BioFluidica, Inc., headquartered in the United States, is a pioneering company in the biotechnology sector, specialising in advanced liquid biopsy solutions. Founded in 2012, BioFluidica has made significant strides in the development of innovative technologies that enhance cancer diagnostics and monitoring, positioning itself as a leader in the field. The company’s core offerings include proprietary microfluidic devices and analytical services that enable the isolation and analysis of circulating tumour cells (CTCs) from blood samples. What sets BioFluidica apart is its commitment to improving patient outcomes through precise and non-invasive testing methods. With a strong focus on research and development, BioFluidica continues to expand its operational reach, contributing to advancements in personalised medicine and cancer care.
DitchCarbon Score
How does BioFluidica, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
BioFluidica, Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
BioFluidica, Inc.'s reported carbon emissions
BioFluidica, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that BioFluidica may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As a result, the company does not inherit any emissions data or targets from a parent organisation, nor does it participate in recognised climate frameworks such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP).
How Carbon Intensive is BioFluidica, Inc.'s Industry?
How Carbon Intensive is BioFluidica, Inc.'s Location?
BioFluidica, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
BioFluidica, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
